MEET OUR TEAM
Alex Blyth

Serial entrepreneur with 15 years’ experience in commercialising novel biopharma assets and strategy consulting, having advised teams and led the strategic planning for bringing to market over 50 assets for companies like Pfizer, Allergan, abbVie, Amgen, Shire, Takeda, GSK & Sanofi. Founded the company after losing his mother to Pancreatic Cancer, and seeing a new way to beat cancer by utilising the innate immune system.

Alex Blyth

Chief Executive Officer

Chief Executive Officer

Chief Technology Officer

To be Announced

Dr. Rebecca Prue

An experienced cell and gene therapy quality assurance specialist with a unique blend of experience in both Quality Management and Production Management of Investigational Medicinal Products (IMPs), including over 15 years Quality Management of cell and gene therapy products. Also an Immunologist whose PhD subject was specifically on Neutrophils.

RP_edited.png

Dr Rebecca Prue

Head of manufacturing & Quality Control

Head of Manufacturing & Quality Control
Dr. Panteli Theocharous

Industry and medical expert with over 25 years of highly successful translational research, clinical, commercial, and international management experience across healthcare, with a focus in Haemato-Oncology. Trained Immunologist with extensive experience in haematopoietic stem cell transplantation and cell therapies. Led the development and launch of several major cancer drugs within Pharma, Biotech and CRO. Former CMO for Cell Therapeutics prior to successful sale.

Panteli photo.jpg

Dr Panteli Theocharous

Chief Medical Officer

Chief Medical Officer
Dr. Dee Athwal

Business advisor with over thirty years’ experience in the pharma and biotech sector, with comprehensive knowledge of drug development, partnering, budgeting, litigation, fund raising, due diligence activities (buy and sell side) and corporate operations. Former CBSO at Capella BioScience and Director of BD for UCB and Celltech

Dr Dee Athwal

Scientific & Development Advisor

Scientific & Development Advisor

RECRUITING

Product Development Project Manager

Dr. Matthew Baker

Immunologist with 15 years R&D experience, has led teams that have designed over 11 antibody therapeutics currently in clinical trials. Developed manufacturing cell lines for the expression of protein therapeutics that have entered multiple clinical trials. Former CSO for multiple successful Biotech’s including Abzena (IPO).

MB.jpeg

Dr Matthew Baker

Chief Scientific Advisor

Chief Scientific Advisor
Andrew Willis

Regulatory advisor with 33 years of experience with regulatory affairs and pharmaceutical development.  Experience at multiple levels within pharmaceutical companies and most recently as Vice President for Regulatory Affairs, gaining significant experience in co-ordinating, planning and running global development projects relating to orphan products and ATMPs.

Andrew Willis

Head of regulations

Head of Regulations

RECRUITING

Research Scientist